Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Microbiology Australia Microbiology Australia Society
Microbiology Australia, bringing Microbiologists together
RESEARCH ARTICLE

Biological warfare: the history of microbial pathogens, biotoxins and emerging threats

Alexa M Kaufer A C , Torsten Theis A , Katherine A Lau A , Joanna L Gray A and William D Rawlinson B
+ Author Affiliations
- Author Affiliations

A Royal College of Pathologists of Australasia Quality Assurance Programs, Biosecurity Department, Sydney, NSW, Australia

B Serology and Virology Division (SAViD), NSW Health Pathology, SOMS and BABS, University of New South Wales, Sydney, NSW, Australia

C Email: alexa.kaufer@rcpaqap.com.au

Microbiology Australia 41(3) 116-122 https://doi.org/10.1071/MA20031
Published: 19 August 2020

Abstract

Bioterrorism is the deliberate misuse of a pathogen (virus, bacterium or other disease-causing microorganisms) or biotoxin (poisonous substance produced by an organism) to cause illness and death amongst the population. Bioterrorism and biological warfare (biowarfare) are terms often used interchangeably. However, bioterrorism is typically attributed to the politically motivated use of biological weapons by a rogue state, terrorist organisation or rogue individual whereas biological warfare refers to a country’s use of bioweapons. Although rare, bioterrorism is a rapidly evolving threat to global security due to significant advancements in biotechnology in recent years and the severity of agents that could be exploited. The pursuit of publicity plays a vital role in bioterrorism. The success of a biological attack is often calculated by the extent of terror resulting from the event, psychological disruption of society and political breakdown, rather than the lethal effects of the agent used.


References

[1]  Venkatesh, S. and Memish, Z.A. (2003) Bioterrorism--a new challenge for public health. Int. J. Antimicrob. Agents 21, 200–206.
Bioterrorism--a new challenge for public health.Crossref | GoogleScholarGoogle Scholar | 12615387PubMed |

[2]  Robertson, A.G. (2000) Bioterrorism: an Australian perspective. ADF Health 1, 99–106.

[3]  Frischknecht, F. (2003) The history of biological warfare. Human experimentation, modern nightmares and lone madmen in the twentieth century. EMBO Rep. 4, S47–S52.
The history of biological warfare. Human experimentation, modern nightmares and lone madmen in the twentieth century.Crossref | GoogleScholarGoogle Scholar | 12789407PubMed |

[4]  Wallin, A. et al. (2007) Public health and bioterrorism: renewed threat of anthrax and smallpox. Medicina (Kaunas) 43, 278–284.
Public health and bioterrorism: renewed threat of anthrax and smallpox.Crossref | GoogleScholarGoogle Scholar | 17485954PubMed |

[5]  Binder, P. et al. (2003) Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy. Comp. Immunol. Microbiol. Infect. Dis. 26, 401–421.
Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy.Crossref | GoogleScholarGoogle Scholar | 12818625PubMed |

[6]  Stockholm International Peace Research Institute (1971) The Problem of Chemical and Biological Warfare: Volume 1: The Rise of CB Weapons. Stockholm: Almqvist & Wiksell.

[7]  Carus, W.S. (2015) The history of biological weapons use: what we know and what we don’t. Health Secur. 13, 219–255.
The history of biological weapons use: what we know and what we don’t.Crossref | GoogleScholarGoogle Scholar | 26221997PubMed |

[8]  Leitenberg, M. et al. (2012) The Soviet Biological Weapons Program: A History. Cumberland, ME: Harvard University Press.

[9]  US Army Medical Department Center and School (2018) Medical Aspects of Biological Warfare. Washington, DC: Department of US Army.

[10]  National Research Council (US) Committee on a New Government–University Partnership for Science and Security (2007) Science and security in a Post 9/11 world: a report based on regional discussions between the science and security communities. Washington, DC: National Academies Press.

[11]  Selgelid, M.J. (2009) Governance of dual-use research: an ethical dilemma. Bull. World Health Organ. 87, 720–723.
Governance of dual-use research: an ethical dilemma.Crossref | GoogleScholarGoogle Scholar | 19784453PubMed |

[12]  Thompson, C. (2006) The bioterrorism threat by non-state actors: hype or horror? Montey, California Naval Postgraduate School.

[13]  Cello, J. et al. (2002) Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297, 1016–1018.
Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.Crossref | GoogleScholarGoogle Scholar | 12114528PubMed |

[14]  Bjørn Jensen, L. et al. (2018) The delivery of health promotion and environmental health services; public health or primary care settings? Healthcare (Basel) 6, 42.
The delivery of health promotion and environmental health services; public health or primary care settings?Crossref | GoogleScholarGoogle Scholar |

[15]  McDade, J.E. (1999) Addressing the potential threat of bioterrorism--value added to an improved public health infrastructure. Emerg. Infect. Dis. 5, 591–592.
Addressing the potential threat of bioterrorism--value added to an improved public health infrastructure.Crossref | GoogleScholarGoogle Scholar | 10458972PubMed |

[16]  Erenler, A.K. et al. (2018) How prepared are we for possible bioterrorist attacks: an approach from emergency medicine perspective. ScientificWorldJournal 2018, 7849863.
How prepared are we for possible bioterrorist attacks: an approach from emergency medicine perspective.Crossref | GoogleScholarGoogle Scholar | 30104916PubMed |

[17]  Buehler, J.W. et al. (2004) Framework for evaluating public health surveillance systems for early detection of outbreaks: recommendations from the CDC Working Group. MMWR Recomm. Rep. 53, 1–11.
| 15129191PubMed |

[18]  Henning, KJ (2004) What is syndromic surveillance? MMWR Suppl 53, 5–11.
| 15714620PubMed |

[19]  McBrien, K.A. et al. (2010) Use of outcomes to evaluate surveillance systems for bioterrorist attacks. BMC Med. Inform. Decis. Mak. 10, 25.
Use of outcomes to evaluate surveillance systems for bioterrorist attacks.Crossref | GoogleScholarGoogle Scholar | 20459679PubMed |

[20]  Feakes, D. (2017) The biological weapons convention. Rev. Sci. Tech. 36, 621–628.
The biological weapons convention.Crossref | GoogleScholarGoogle Scholar | 30152458PubMed |

[21]  Riedel, S. (2004) Biological warfare and bioterrorism: a historical review. Proc. Bayl. Univ. Med. Cent. 17, 400–406.
Biological warfare and bioterrorism: a historical review.Crossref | GoogleScholarGoogle Scholar | 16200127PubMed |

[22]  Wang, F. and Zhang, W. (2019) Synthetic biology: recent progress, biosafety and biosecurity concerns, and possible solutions. Journal of Biosafety and Biosecurity 1, 22–30.
Synthetic biology: recent progress, biosafety and biosecurity concerns, and possible solutions.Crossref | GoogleScholarGoogle Scholar |